Assessment of the relationship between the concentration of PSGL-1, NO-synthases and nitric oxide metabolites in the blood serum of patients with acute arterial thrombosis. Problems of biological, medical and pharmaceutical chemistry

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. PSGL-1 is a complex protein, that provides contacts between blood cells and endothelial cells by connecting with cell-adhesion molecules selectins, and it is a universal participant in the processes of leukocyte adhesion, inflammation and immune response. The study of the possible regulation of its functioning is an urgent topic, since the process of its interactions with selectins can be a point of therapeutic application.

Aim of the study. Evaluation of the relationship between the concentration of universal ligand selectins PSGL-1, inducible (iNOS) and endothelial (eNOS) NO synthases and final metabolites of nitric oxide (II) in the blood serum of patients with acute arterial thrombosis.

Material and methods. The concentrations of PSGL-1, iNOS and eNOS in blood serum were determined, using enzyme immunoassay on an enzyme immunoassay analyzer Stat Fax 2100. The total concentration of the final stable metabolites of nitric oxide(II) (nitrates and nitrites) was determined by the spectrophotometric method modified by V.A. Metelskaya, by coloring in the reaction of diazotization with nitrite of sulfonamide present in the composition of the Griss reagent.

The results were processed, using nonparametric statistics methods of Microsoft Office Excel 2016 and IBM SPSS Statistics 26 (StatSoftInc., USA).

Results. The study revealed a statistically significant increase in the level of endothelial nitric oxide synthase and the final stable metabolites of nitric oxide in the blood of patients with acute arterial thrombosis, compared with the control group. A direct correlation of moderate severity was also found between the level of eNOS and the concentration of nitrates and nitrites. A low positive correlation was found between the concentration of PSGL-1 and the level of eNOS, and a low negative correlation was found between PSGL-1 and iNOS.

Conclusions. According to the results of the study, it can be concluded that nitric oxide, which generated by endothelial NO synthase in patients with arterial thrombosis, may have a regulatory effect on the expression or functioning of the universal glycoprotein ligand of selectins – PSGL-1, which requires more in-depth study.

Full Text

Restricted Access

About the authors

N. V. Korotkova

Ryazan State Medical University named after academician I.P. Pavlov

Author for correspondence.
Email: fnv8@yandex.ru
ORCID iD: 0000-0001-7974-2450

Ph.D. (Med.), Associate Professor of the Department of Biological Chemistry, Senior Research Scientist, Central Research Laboratory

Russian Federation, Vysokovoltnaya str., 9, 390026, Ryazan

R. E. Kalinin

Ryazan State Medical University named after academician I.P. Pavlov

Email: kalinin-re@yandex.ru
ORCID iD: 0000-0002-0817-9573

Dr.Sc. (Med.), Professor, Head of the Department of Cardiovascular, Endovascular Surgery, and Diagnostic Radiology

Russian Federation, Vysokovoltnaya str., 9, 390026, Ryazan

I. A. Suchkov

Ryazan State Medical University named after academician I.P. Pavlov

Email: i.suchkov@rzgmu.ru
ORCID iD: 0000-0002-1292-5452

Dr.Sc. (Med.), Professor, Professor of the Department of Cardiovascular, Endovascular Surgery, And Diagnostic Radiology

Russian Federation, Vysokovoltnaya str., 9, 390026, Ryazan

N. D. Mzhavanadze

Ryazan State Medical University named after academician I.P. Pavlov

Email: nina_mzhavanadze@mail.ru
ORCID iD: 0000-0001-5437-1112

Dr.Sc. (Med.), Associate Professor, Department of Cardiovascular, Endovascular Surgery and Diagnostic Radiology, Senior Research Scientist, Central Research Laboratory

Russian Federation, Vysokovoltnaya str., 9, 390026, Ryazan

A. A. Nikiforov

Ryazan State Medical University named after academician I.P. Pavlov

Email: alnik003@yandex.ru
ORCID iD: 0000-0001-9742-4528

Ph.D. (Med.), Associate Professor of the Department of Pharmacology, Head of the Central Research Laboratory

Russian Federation, Vysokovoltnaya str., 9, 390026, Ryazan

S. I. Fomina

Ryazan State Medical University named after academician I.P. Pavlov

Email: sof.fomina2017@yandex.ru
ORCID iD: 0009-0004-2731-5579

Student, Faculty of Medicine

Russian Federation, Vysokovoltnaya str., 9, 390026, Ryazan

A. D. Alekseenko

First Moscow State Medical University (Sechenov University)

Email: alekseenko_anna13@mail.ru
ORCID iD: 0009-0002-3400-5355

Student, N.V. Sklifosovsky Institute of Clinical Medicine

Russian Federation, Trubetskaya str., 8, building 2, 119048, Moscow

References

  1. Tvaroška I., Selvaraj C., Koča J. Selectins – The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules – a Review. Molecules. 2020; 25(12): 2835. doi: 10.3390/mole-cules25122835.
  2. Wagner D.D., Frenette P.S. The vessel wall and its interactions. Blood. 2008; 111(11): 5271–5281. doi: 10.1182/blo-od-2008-01-078204.
  3. Belyaev A.V., Fedotova I.V. Molecular mechanisms of catch bonds and their implications for platelet hemostasis. Biophysical Reviews. 2023; 15: 1233–1256. doi: 10.1007/s12551-023-01144-8.
  4. Rivera-Nieves J., Burcin T.L., Olson T.S., et al. Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis. J. Exp. Med. 2006; 203: 907–917. doi: 10.1084/jem.20052530.
  5. McEver R.P., Cummings R.D. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest. 1997; 100(11 Suppl): S97–103. doi: 10.1172/jci119556.
  6. Shao B., Yago T., Setiadi H., et al. O-glycans direct selectin ligands to lipid rafts on leukocytes. Proc Natl Acad Sci USA. 2015; 112(28): 8661–8665. doi: 10.1073/pnas.1507712112.
  7. Ley K., Kansas G.S. Selectins in T-cell recruitment to nonlymphoid tissues and sites of inflammation. Nat. Rev. Immunol. 2004; 4: 325–35. doi: 10.1038/nri1351.
  8. Sako D., Chang X.J., Barone K.M., et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 1993; 75: 1179–1186. doi: 10.1016/0092-8674(93)90327-m.
  9. Pruenster M., Kurz A.R.M., Chung K.-J., et al. Extracellular MRP8/14 is a regulator of β2 integrin-dependent neutrophil slow rolling and adhesion. Nat Commun. 2015; 20(6): 6915. doi: 10.1038/ncomms7915.
  10. Abadier M., Ley K. P-selectin glycoprotein ligand-1 in T cells. Curr. Opin.Hematol. 2017; 24(3): 265–273. doi: 10.1097/MOH.0000000000000331.
  11. Chaitanya G.V., Cromer W., Wells S., et al. Metabolic modulation of cytokine-induced brain endothelial adhesion molecule expression. Microcirculation. 2012; 19(2): 155–165. doi: 10.1111/j.1549-8719.2011.00141.x.
  12. Пожилова Е.В., Новиков В.Е. Синтаза оксида азота и эндогенный оксид азота в физиологии и патологии клетки. Вестник Смоленской государственной медицинской академии. 2015. 14;(4):35–41. [Pozhilova E.V., Novikov V.E.
  13. Sintaza oksida azota i jendogennyj oksid azota v fiziologii i patologii kletki. Vestnik Smolenskoj gosudarstvennoj medicinskoj akademii. 2015; 14(4): 35–41. (In Russ.)].
  14. Калинин Р.Е., Сучков И.А., Мжаванадзе Н.Д., и др. Метаболиты оксида азота при развитии осложнений после открытых реконструктивных вмешательств у пациентов с периферическим атеросклерозом. Наука молодых (Eruditio Juvenium). 2021; 9(3): 407–414. [Kalinin R.E., Suchkov I.A., Mzhavanadze N.D., i dr. Metabolity oksida azota pri razvitii oslozhnenij posle otkrytyh rekonstruktivnyh vmeshatel'stv u pacientov s perifericheskim aterosklerozom. Nauka molodyh (Eruditio Juvenium). 2021; 9(3): 407–414. (In Russ.)]. doi: 10.23888/HMJ202193407-414. doi: 10.23888/HMJ202193407-414.
  15. Пожилова Е.В., Новиков В.Е., Левченкова О.С. Активные формы кислорода в физиологии и патологии клетки. Вестник Смоленской государственной медицинской академии. 2015; 14(2): 13–22. [Pozhilova E.V., Novikov V.E., Levchenkova O.S. Aktivnye formy kisloroda v fiziologii i patologii kletki. Vestnik Smolenskoj gosudarstvennoj medicinskoj akademii. 2015; 14(2):13–22. (In Russ.)].
  16. Tinoco R., Otero D.C., Takahashi A.A., Bradley L. M. PSGL-1: A New Player in the Immune Checkpoint Landscape. Trends immunology. 2017; 38(5): 323–335. doi: 10.1016/j.it.2017.02.002.
  17. Калинин Р.Е., Сучков И.А., Климентова Э.А., и др. Биомаркеры апоптоза и пролиферации клеток в диагностике прогрессирования атеросклероза в различных сосудистых бассейнах. Российский медико-биологический вестник им. академика И.П. Павлова. 2022; 30(2): 243–252. [Kalinin R.E., Suchkov I.A., Klimentova Je.A., i dr. Biomarkery apoptoza i proliferacii kletok v diagnostike progressirovanija ateroskleroza v razlichnyh sosudistyh bassejnah. Rossijskij mediko-biologicheskij vestnik im. akademika I.P. Pavlova. 2022; 30(2): 243–252. (In Russ.)]. doi: 10.17816/PAVLOVJ88938.
  18. Короткова Н.В., Калинин Р.Е., Сучков И.А., и др. Оценка уровня селектинов и гликопротеинового лиганда PSGL-1 у пациентов с артериальным тромбозом. Технологии живых систем. 2023; 20(4): 72–79. [Korotkova N.V., Kalinin R.E., Suchkov I.A., i dr. Ocenka urovnja selektinov i glikoproteinovogo liganda PSGL-1 u pacientov s arterial'nym trombozom. Tehnologii zhivyh sistem. 2023; 20(4): 72–79. (In Russ.)]. doi: 10.18127/j20700997-202304-07.
  19. Costa D., Benincasa G., Lucchese R., et.al. Effect of nitric oxide reduction on arterial thrombosis. R Scand Cardiovasc J. 2019; 53(1): 1–8. doi: 10.1080/14017431.2019.1581943.
  20. Navasardyan I., Bonavida B. Regulation of T cells in cancer by nitric oxide. Cells. 2021; 10: 2655. doi: 10.3390/cells10102655.
  21. Галагудза М.М., Бельский Ю.П., Бельская Н.В. Индуцибельная NO-синтаза как фармакологическая мишень противовоспалительной терапии: надежда не потеряна? Сибирский журнал клинической и экспериментальной медицины. 2023; 38(1): 13–20. [Galagudza M.M., Bel'skij Ju.P., Bel'skaja N.V. Inducibel'naja NO-sintaza kak farmakologicheskaja mishen' protivovospalitel'noj terapii: nadezhda ne poterjana? Sibirskij zhurnal klinicheskoj i jeksperimental'noj mediciny. 2023; 38(1): 13–20. (In Russ.)]. doi: 10.29001/2073-8552-2023-38-1-13-20.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. The level of NO synthases in the blood serum of patients compared with the control group; * – statistically significant differences from the control group (p ≤ 0.05)

Download (34KB)
3. Fig. 2. Concentration of stable end metabolites of nitric oxide in the blood serum of patients compared to the control group; * – statistically significant differences from the control group (p ≤ 0.05)

Download (41KB)

Copyright (c) 2024 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies